Weaving evidence into practice: expert perspectives on treating NDMM in 2026
Thursday 14th May, 14:00-15:15 CEST
The symposium will open with a thought-provoking quick-fire panel discussion exploring how anti-CD38-containing regimens have transformed outcomes in NDMM over recent years and the resulting impact on both HCPs and patients. The following case-based session will examine diverse patient profiles across TE and TIE NDMM, exploring differing treatment goals and strategies which can be tailored to individual patients.
| AGENDA | |
|---|---|
| 14:00-14:10 | An introduction: how anti-CD38 therapies have sewed new standards into practice Prof. Yael Cohen (Chair) to present and moderate discussion between Prof. Salomon Manier, Prof. Philippe Moreau, and Prof. Catarina Geraldes |
| 14:10–14:50 | Maximising outcomes for patients with NDMM: a fabric of perspectives from the clinic Case studies presented by Prof. Salomon Manier, Prof. Yael Cohen, and Prof. Philippe Moreau; Prof. Yael Cohen (Chair) to moderate discussion |
| 14:50–15:05 | Advancing NDMM management: weaving convenience into care Dr Sarah Farmer to present and participate in audience Q&A |
| 15:05-15:15 | Q&A and close Prof. Salomon Manier, Prof. Philippe Moreau, and Prof. Catarina Geraldes to participate in Q&A, facilitated by Prof. Yael Cohen (Chair) |
EM-201659
Date of Prep: May 2026
